Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule of the upcoming investor calls.09-11-2020
09-11-2020
Syngene International Ltd - 539268 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015
Please find attach the Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 201503-11-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule of the upcoming investor call02-11-2020
Syngene eases clients' path to drug discovery
Syngene International an integrated research, development and manufacturing services company has tasted success in drug discovery. The company has30-10-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached the copy of the Advertisement of the Financial Results in Newspapers23-10-2020
Buy Syngene International; target of Rs 640: Dolat Capital Market
Dolat Capital Market is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 640 in its research report dated October 22, 2020.23-10-2020
Earnings Call Transcript - Q2FY21 for Syngene International
Conference Call with Syngene International Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.22-10-2020
Syngene International drops over 5% on Q2 results
A robust operating performance during the second quarter of the current fiscal has helped Syngene International Ltd to post a 2 per cent increase in n22-10-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached the Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 201521-10-2020